Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, March 8, 2024
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
[ Fri, Mar 08th 2024
] - WOPRAI
Ed Arce Reiterated (ARCT) at Strong Buy and Held Target at $60 on, Mar 8th, 2024
Ed Arce of HC Wainwright & Co., Reiterated "Arcturus Therapeutics Holdings Inc." (ARCT) at Strong Buy and Held Target at $60 on, Mar 8th, 2024.
Ed has made no other calls on ARCT in the last 4 months.
There are 2 other peers that have a rating on ARCT. Out of the 2 peers that are also analyzing ARCT, 0 agree with Ed's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Ed
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $48 on, Thursday, February 8th, 2024
- Whitney Ijem of "Canaccord Genuity" Initiated at Strong Buy on, Wednesday, December 13th, 2023
